HomeCompareHERF vs PFE

HERF vs PFE: Dividend Comparison 2026

HERF yields 30769.23% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HERF wins by $3.799364689394562e+21M in total portfolio value
10 years
HERF
HERF
● Live price
30769.23%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.799364689394562e+21M
Annual income
$3,775,228,738,797,350,000,000,000,000.00
Full HERF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — HERF vs PFE

📍 HERF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHERFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HERF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HERF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HERF
Annual income on $10K today (after 15% tax)
$2,615,384.62/yr
After 10yr DRIP, annual income (after tax)
$3,208,944,427,977,748,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, HERF beats the other by $3,208,944,427,977,748,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HERF + PFE for your $10,000?

HERF: 50%PFE: 50%
100% PFE50/50100% HERF
Portfolio after 10yr
$1.899682344697281e+21M
Annual income
$1,887,614,369,398,675,000,000,000,000.00/yr
Blended yield
99.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HERF
No analyst data
Altman Z
-9297.4
Piotroski
0/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HERF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHERFPFE
Forward yield30769.23%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$3.799364689394562e+21M$49.6K
Annual income after 10y$3,775,228,738,797,350,000,000,000,000.00$26,258.71
Total dividends collected$3.797776891400928e+21M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HERF vs PFE ($10,000, DRIP)

YearHERF PortfolioHERF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$3,087,623$3,076,923.08$9,153$693.39+$3.08MHERF
2$891,189,616$887,885,859.65$8,593$849.25+$891.18MHERF
3$240,461,119,088$239,507,546,198.72$8,336$1,066.78+$240461.11MHERF
4$60,653,570,624,041$60,396,277,226,616.16$8,437$1,384.80+$60653570.62MHERF
5$14,302,535,819,849,862$14,237,636,499,282,138.00$9,013$1,875.40+$14302535819.84MHERF
6$3,152,999,212,134,337,000$3,137,695,498,807,097,300.00$10,306$2,680.72+$3152999212134.33MHERF
7$649,828,018,912,462,400,000$646,454,309,755,478,600,000.00$12,820$4,101.38+$649828018912462.38MHERF
8$125,212,310,148,578,160,000,000$124,516,994,168,341,850,000,000.00$17,673$6,826.70+$125212310148578160.00MHERF
9$22,556,963,174,964,770,000,000,000$22,422,986,003,105,790,000,000,000.00$27,543$12,591.86+$22556963174964768768.00MHERF
10$3,799,364,689,394,562,000,000,000,000$3,775,228,738,797,350,000,000,000,000.00$49,560$26,258.71+$3.799364689394562e+21MHERF

HERF vs PFE: Complete Analysis 2026

HERFStock

Red Oak Hereford Farms, Inc. through its subsidiaries, Red Oak Farms, Inc. and My Favorite Jerky, LLC markets branded fresh beef and processed beef products. Its products are distributed to retail supermarkets, and food service and direct sales markets located throughout the United States. The company, through its wholly owned subsidiary, Midland Cattle Company, Inc., buys and sells feeder cattle in the wholesale market. Its sales primarily include fresh-boxed beef in traditional primals, such as short loins, ribs, chucks, rounds and frozen-boxed primals. It is also planning to acquire and process products, along with its beef, to produce convenience meals, including its Premium Beef precooked products, frozen ground chuck patties, additional precooked offerings, beef jerky, and sticks.

Full HERF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HERF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HERF vs SCHDHERF vs JEPIHERF vs OHERF vs KOHERF vs MAINHERF vs JNJHERF vs MRKHERF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.